Literature DB >> 25221661

Synthesis of novel tylophorine derivatives and evaluation of their anti-inflammatory activity.

Ti Wen1, Ziwen Wang2, Xianyi Meng3, Meng Wu4, Yangguang Li3, Xiaoli Wu3, Liqing Zhao3, Puyue Wang3, Zhinan Yin3, Jesse Li-Ling5, Qingmin Wang4.   

Abstract

We have previously demonstrated that DCB-3503, a tylophorine analogue, has an anti-inflammatory property in murine models for autoimmune diseases. However, its mechanism remains unknown. Here, we have synthesized 34 derivatives of DCB-3503 and investigated their effects on T cells differentiation and TNF-α production. Six derivatives (4, 9, 13, 19, 31, and 32) could significantly promote the expression of Foxp3. Among these, the IC50 of 31 and 32 was about 500 μM. Eight analogues (1, 2, 4, 9, 12, 18, 19, and 21) showed anti-TNF-α effect in Raw 264.7 cells and murine splenocytes, of which 18 and 19 were most significant. Moreover, 31 and 18 showed a better activity and cell survival ratio when compared with DCB-3503 at various concentrations. In summary, we have demonstrated the anti-inflammatory characteristics of 34 novel tylophorine derivatives and discussed their structure-activity relationship in order to explore their therapeutic potentials for inflammatory diseases.

Entities:  

Keywords:  Foxp3; TNF-α; Tylophorines derivatives; anti-inflammatory activity

Year:  2014        PMID: 25221661      PMCID: PMC4160763          DOI: 10.1021/ml500255j

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  28 in total

Review 1.  Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.

Authors:  W J Sandborn; S B Hanauer
Journal:  Inflamm Bowel Dis       Date:  1999-05       Impact factor: 5.325

2.  Phenanthroindolizidine alkaloids as cytotoxic substances in a Danaid butterfly, Ideopsis similis, against human cancer cells.

Authors:  H Komatsu; M Watanabe; M Ohyama; T Enya; K Koyama; T Kanazawa; N Kawahara; T Sugimura; K Wakabayashi
Journal:  J Med Chem       Date:  2001-05-24       Impact factor: 7.446

3.  In vitro cytotoxic activity of phenanthroindolizidine alkaloids from Cynanchum vincetoxicum and Tylophora tanakae against drug-sensitive and multidrug-resistant cancer cells.

Authors:  Dan Staerk; Anne K Lykkeberg; Jette Christensen; Bogdan A Budnik; Fumiko Abe; Jerzy W Jaroszewski
Journal:  J Nat Prod       Date:  2002-09       Impact factor: 4.050

4.  A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.

Authors:  S E Plevy; C J Landers; J Prehn; N M Carramanzana; R L Deem; D Shealy; S R Targan
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

Review 5.  Anti-TNF treatment in rheumatoid arthritis.

Authors:  Janina Geiler; Maya Buch; Michael F McDermott
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

6.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

7.  Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab.

Authors:  C Taxonera; J Estellés; I Fernández-Blanco; O Merino; I Marín-Jiménez; M Barreiro-de Acosta; C Saro; V García-Sánchez; E Gento; G Bastida; J P Gisbert; I Vera; P Martinez-Montiel; S Garcia-Morán; M C Sánchez; J L Mendoza
Journal:  Aliment Pharmacol Ther       Date:  2010-12-07       Impact factor: 8.171

Review 8.  Development of anti-TNF therapy for rheumatoid arthritis.

Authors:  Marc Feldmann
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

9.  Synthesis and SAR studies of phenanthroindolizidine and phenanthroquinolizidine alkaloids as potent anti-tumor agents.

Authors:  Ziwen Wang; Meng Wu; Yi Wang; Zheng Li; Lei Wang; Guifang Han; Fazhong Chen; Yuxiu Liu; Kailiang Wang; Ao Zhang; Linghua Meng; Qingmin Wang
Journal:  Eur J Med Chem       Date:  2012-03-02       Impact factor: 6.514

10.  Novel mode of action of tylophorine analogs as antitumor compounds.

Authors:  Wenli Gao; Wing Lam; Sanbao Zhong; Conrad Kaczmarek; David C Baker; Yung-Chi Cheng
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

View more
  1 in total

1.  Total synthesis of the reported structure of 13a-hydroxytylophorine.

Authors:  Hui Zhang; Gang Li; Bo Su; Meng Deng; Yu-Xiu Liu; Yu-Cheng Gu; Qing-Min Wang
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.